TRACKER’s First Year: Transforming Lung Cancer Research

---

As TRACKER Biobank marks its remarkable first year, we celebrate a year of innovation, collaboration, and progress. Together with patients, clinicians, and researchers, TRACKER is advancing the future of lung cancer care.

---

Building a National Network

In its inaugural year, TRACKER successfully established a robust national presence by securing nine clinical sites across five Australian states. This network is key to collecting the vital patient samples needed to drive transformative research in lung cancer. 

Empowering Research Through Generosity

Thanks to the selflessness of 97 lung cancer patients, recruited through Austin Health and The Royal Melbourne Hospital, TRACKER has processed an extraordinary 3,222 vials of tissue, blood, lung fluid, and their derivatives. These invaluable samples are now actively enabling cutting-edge research to: 

• 🔬 Predict and prevent treatment-related side effects, improving patient safety. 

• 🛡️ Combat treatment resistance, providing hope for those facing difficult challenges. 

• 🌟 Enhance care & outcomes, advancing personalised medicine for lung cancer patients. 

"Every Sample Makes a Difference.”

_____________

TRACKER Team 

Looking to the future

TRACKER’s first year has laid a strong foundation, but the journey is just beginning. With ongoing collaboration and support, 2025 is set to bring even greater achievements in lung cancer research, making a lasting impact on patient care. 

To our patients, consumers, researchers, and clinical partners — thank you for your trust, generosity, and dedication. Together, we are driving change and creating a brighter future for lung cancer patients everywhere. 

Stay connected for more updates as TRACKER continues to push the boundaries of innovation in the year ahead!